This week M&A has featured prominently.
Beginning in the United States, Eldorado Resorts reached an agreement to acquire Tropicana Entertainment for $1.85 billion. The deal will see the acquirer take over the operation of seven casinos in six states.
Nasdaq-listed Hilton Worldwide Holdings has undertaken a secondary share offering, raising $4.8 billion.
The Bank of Montreal has issued $2.25 billion in senior notes - $1.5 billion 3.1% notes and $750 million floating rate notes.
Vermilion Energy is set to acquire Spartan Energy for C$1.4 billion in a stock deal.
Weir has reached an agreement to take over ESCO for $1.05 billion.
In the Czech Republic, Advent International is set to acquire Zentiva for €1.91 billion from Sanofi. Zentiva is Sanofi’s European generics business.
In a cross-border deal between Belgium and Italy, Athora Holding has reached an agreement to take over Generali's Belgium business for €540 million.
In France, Total is aiming to buy a majority stake in Direct Energie for €1.4 billion.
In Germany, Procter & Gamble is set to acquire Merck's consumer health business for $4.2 billion.
Richemont International Holding has undertaken a €4 billion notes issue in the United Kingdom. The issue consisted of €1.5 billion 1% notes due 2026, €1.25 billion 1.5% notes due 2030, and €1.25 billion 2% notes due 2038.
Another cross-border deal – this time between France, Ireland and the United Kingdom – has seen Servier reach an agreement to take over Shire’s oncology business for $2.4 billion.
Japan’s Takeda Pharmaceutical, meanwhile, has had a $63 billion bid for Shire rejected.
Singapore’s Temasek is set to acquire a 3.6% stake in Bayer for $3.7 billion as Bayer raises funds for its acquisition of Monsanto.
In Turkey, Yildiz Holding is restructuring $6.5 billion of its debt.